Instagram CEO Defends Platform in Youth Mental Health Lawsuit Over Social Media Addiction Claims 
Gates Foundation Denies Financial Ties to Jeffrey Epstein Following DOJ Email Release 
AbbVie Sues HHS Over Medicare Price Controls on Botox Under Inflation Reduction Act 
FAA Confirms $1.5 Billion Peraton Contract as U.S. Air Traffic Control Overhaul Accelerates 
How Marco Pharma International Preserves German Homeopathic Traditions in America 
ANZ Shares Hit Record High After Strong Q1 Profit and Cost-Cutting Gains 
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine 
U.S. Commerce Department Reaches $252 Million Settlement With Applied Materials Over China Exports 
Standard Chartered Names Peter Burrill as Interim Group CFO Following Diego De Giorgi’s Exit 
Ralph Lauren Unveils Elegant Fall 2026 Women’s Collection Ahead of New York Fashion Week 
More U.S. Investors Join Arbitration Against South Korea Over Coupang Dispute 
Russia Moves to Fully Block WhatsApp as Kremlin Pushes State-Backed MAX App 
Lyft Shares Slide After Weak Q1 Profit Forecast and Surprise 2025 Operating Loss 
FTC Questions Apple News Over Alleged Bias Against Conservative Media 
CBA Shares Surge After Record Half-Year Profit as Rate Outlook Improves 
Novocure Stock Surges 30% After FDA Approves Optune Pax for Pancreatic Cancer Treatment 
REDWOOD CITY, Calif., Nov. 09, 2017 -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at two investment conferences in November:
- 8th Annual Craig-Hallum Alpha Select Conference on Thursday, November 16, 2017 at 9:20 a.m. Eastern time (6:20 a.m. Pacific time). The conference is being held at the Sheraton Times Square Hotel in New York City.
- Furey Research Hidden Gems Conference on Thursday, November 16, 2017 at 2:45 p.m. Eastern time (11:45 a.m. Pacific time). The conference is being held at the University Club of New York in New York City.
A live webcast and replay of the presentation at the Craig-Hallum Alpha Select Conference will be available on the Investors section of the company’s website, http://ir.codexis.com/.
About Codexis, Inc.
Codexis, Inc. is a leading protein engineering company that applies its technology to the development of biocatalysts for commercial manufacture of pharmaceuticals and fine chemicals, as well as the development of enzymes as biotherapeutics and for molecular diagnostics. Codexis’ proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. For more information, see www.codexis.com.
Contacts:
Investors
LHA Investor Relations
Jody Cain, 310 691 7100
[email protected]
